Community/Retail

The findings are the first to explain the mechanisms of any Kawasaki disease, a rare childhood inflammatory condition that is triggered by different viruses.

Austedo XR will be available in 3 extended-release tablet strengths, which provides an updated regimen that may result in a lower pill count for patients.

USP executive notes importance of including different voices, perspectives for expansion of quality medicine.

Antibodies from an original COVID-19 vaccination may treat the mRNA booster vaccine as a virus that needs to be cleared.

The latest data indicate that the formulation can provide up to 6 months of full protection against multiple virus challenges.

The risk of new-onset cardiometabolic diseases was significantly elevated post-COVID-19 infection compared to pre-COVID-19 infection.

Health care providers prescribe naloxone to 1 in every 70 patients prescribed a high-dose opioid medication.

Matt Gibbs, president of Capital Rx, discusses alternative career paths in independently owned PBMs.

This episode features Kathy Pham, PharmD, BCPPS, who discusses her experience at the American College of Clinical Pharmacy (ACCP) and why advocacy is important to health care and the pharmacy profession.

Although naloxone is already available without a prescription in all 50 states, not all pharmacies carry it and those that do must keep it behind the counter.

Pharmacies have long embraced innovation and technology, with early adoption of telehealth and digital platforms.

Patients with heart failure are at a significant risk of cardiorenal diseases, highlighting the need for improved treatments and cost management.

Link between male or female sex and the severity of COVID-19 may be found in a subset of regulatory T cells.

Past proposal gives insight into lawmakers' thinking about medicinal use of cannabis on a federal level.

Under the EUA, the Xpert Mpox test is considered authorized for use in moderately complex point-of-care settings using the GeneXpert Xpress system.

Students may be hesitant to discuss migraines, which can lead to absences, difficulties in personal life, financial burdens, and poor mental health.

Analysis shows average monthly premiums for stand-alone plans will rise 10% to $43.

Relative efficacy of nirmatrelvir–ritonavir appears similar across risk groups, but older adults at risk of severe COVID-19 may benefit more.

Study findings confirmed that in asthma, chronic obstructive pulmonary disease, HIV, and influenza, census data differed from the epidemiological data.

The new findings, which include updated data, contradict results of a previous analysis by the same investigators.

Amanda Ryan, the director of Education for the Pharmacy Quality Alliance (PQA), discusses a new PQA program to teach pharmacy and other health professions students the basics of quality measurement and strategies to improve medication safety, adherence and appropriate use.

Study shows no robust differences in blood pressure, heart rate, lipids, and glucose measurements in children conceived using assisted reproductive technologies.

Results of 2 phase 3 clinical trials demonstrate better response rate beyond the primary endpoint analysis at week 16 to more than 55 at week 55.

Investigators focus on whether legalization of the drug is associated with an increase in health care use for the psychotic disorder.

Streptolysin O appears to influence the pathogenesis of Streptococcus group A and direct mutation-mediated virulence in a host.

The association with subgroups of gene variations based on expression or function should be assessed in larger studies, investigators say.

Expanded indication for abrocitinib (Cibinqo; Pfizer Inc) includes patients 12 to <18 years of age with refractory, moderate-to-severe atopic dermatitis that is not adequately controlled with other systemic medications.

Learn strategies to safeguard use of the intravenous administration products to protect patients.